Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area

Molecular Brain Research

Volumn 43, Issue 1-2, 1996, Pages 291-300

  Adelbrecht, Christine ^a   Agid, Yves ^a   Raisman Vozari, Rita ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dopamine membrane transporter; Hybridization; in situ; Parkinson's disease; Tyrosine hydroxylase; Vesicular monoamine transporter; Weaver mutation

Indexed keywords

DOPAMINE TRANSPORTER; MESSENGER RNA; MONOAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; MOUSE; MOUSE MUTANT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, NEUROLOGIC MUTANTS; MUTATION; NERVE TISSUE PROTEINS; NEUROPEPTIDES; SUBSTANTIA NIGRA; TEGMENTUM MESENCEPHALI; TYROSINE 3-MONOOXYGENASE; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

ANIMALIA;

EID: 0030608518     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00214-8     Document Type: Article

References (58)

1. Augood, S., Westmore, K., McKenna, P.J. and Emson, P.C., Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in the ventral mesencephalic neurons, Mol. Brain Res., 20 (1993) 328-334.
2. Bannon, M.J., Poosch, M.S., Xia, Y., Goebel, D.J., Cassin, B. and Kapatos, G., Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age, Proc. Natl. Acad. Sci. USA, 89 (1992) 7095-7099.
3. Barthel, F., Boutillier, A.L., Trouslard, J. and Loefeler, J.P., Fine tuning of calcium entry into neurons regulates adenosine 3′-5′ monophosphate-dependent transcription by several distinct mechanisms, Neuroscience, 70 (1996) 1053-1065.
4. Bernard, V., Gardiol, A., Faucheux, B., Bloch, B., Agid, Y. and Hirsch, E.C., Expression of glutamate receptors in the human and rat basal ganglia. Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion, J. Comp. Neurol., 368 (1996) 553-568.
5. Blanchard, V., Raisman-Vozari, R., Vyas, S., Michel, P., Javoy-Agid, F., Uhl, G. and Agid, Y., Differential expression of tyrosine hydroxylase and membrane dopamine transport genes in subpopulations of dopaminergic neurons of rat mesencephalon, Mol. Brain Res., 22 (1994) 29-40.
6. Cerruti, C., Walther, D.M., Kuhar, M.J. and Uhl, G.R., Dopamine transporter mRNA expression is intense in the rat midbrain neurons and modest outside midbrain, Mol. Brain Res., 18 (1993) 181-186.
7. Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, Z.B., Ince, E., Hersch, S.M., Niznik, H.B. and Levey, A.I., The dopamine transporter: immunochemical characterization and localization in brain, J. Neurosci., 15 (1995) 1714-1723.
8. 3H]dopamine uptake, Exp. Brain Res., 77 (1989) 552-568.
9. Fischer-Bovenkerk, C., Kish, P.E. and Ueda, T., ATP-dependent glutamate uptake into synaptic vesicles from cerebellar mutant mice, J. Neurochem., 51 (1988) 1054-1059.
10. Ghetti, B. and Triarhou, L.C., Degeneration of mesencephalic dopamine neurons in weaver mutant mice, Neurochem. Int., Suppl. 20 (1992) 305S-307S.
11. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, 379 (1996) 606-612.
12. Giros, B., Mestikawy, S.E., Bertrand, L. and Caron, M.G., Cloning and functional characterization of cocaine-sensitive dopamine transporter, FEBS Lett., 295 (1991) 149-154.
13. Graybiel, A.M., Ohta, K. and Roffler-Tarlov, S., Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments, J. Neurosci., 10 (1990) 720-733.
14. Grima, B., Lamouroux, A., Blanot, F., Foucon biguet, N. and Mallet, J., Complete coding sequences of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. USA, 82 (1985) 617-621.
15. Gu, H.H., Wall, S. and Rudnick, G., Ion coupling stoichiometry for the norepinephrine in membrane vesicles from stably transfected cells, J. Biol. Chem., 271 (1996) 6911-6916.
16. Gupta, M., Felten, D.L. and Ghetti, B., Selective loss of monoaminergic neurons in the weaver mutant mice: an immunocytochemical study, Brain Res., 402 (1987) 379-382.
17. Harrington, K.A., Augood, S.J., Kingsbury, A.E., Foster, O.J.F. and Emson, P.C., Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease, Mol. Brain Res., 36 (1996) 157-162.
18. Ichikawa, S., Sasaoka, T. and Nagatsu, T., Primary structure of the mouse tyrosine hydroxylase deduced from its cDNA, Biochem. Biophys. Res. Commun., 176 (1991) 1610-1616.
19. Javoy-Agid, F., Hirsch, E.C., Dumas, S., Duyckaerts, C., Mallet, J. and Agid, Y., Decrease tyrosine hydroxylase messenger RNA in the surviving dopaminergic neurons of the substantia nigra in Parkinson's disease: an in situ hybridization, Neuroscience, 38 (1990) 245-253.
20. Kaneda, N., Sasaoka, T., Kobayashi, K., Kiuchi, K., Nagatsu, I., Kurosawa, Y., Fujita, K., Yokohama, M., Nomura, T., Katsuki, M. and Nagatsu, T., Tissue-specific and high-level expression of human tyrosine hydroxylase gene in transgenic mice, Neuron, 6 (1991) 583-594.
21. Kiyama, H., Emson, P.C., Ruth, J. and Morgan, C., Sensitive non-radioisotopic in situ hybridization histochemistry: demonstration of TH gene expression in the rat brain, Mol. Brain Res., 7 (1990) 213-219.
22. Krejci, E., Gasnier, B., Botton, D., Isambert, M.F., Sagne, C., Gagno, J., Massoulie, J. and Henry, J.P., Expression and regulation of the bovine vesicular monoamine transporter gene, FEBS Lett., 335 (1993) 27-32.
23. Lane, P.W., Mouse Newsletter, 30 (1986) 485-507.
24. Langston, J.W. and Irwin, I., MPTP: current concepts and controversies, Clin. Neuropharmacol., 9 (1986) 485-507.
25. + channels in the brain, FEBS Lett., 353 (1994) 37-42.
26. Liu, Y., Peter, D., Roghani, A., Schuldiner, S., Privé, G.G., Eisenberg, D., Brecha, N. and Edwards, R.H., A cDNA that supresses MPP+ toxicity encodes a vesicular amine transporter, Cell, 70 (1992) 539-551.
27. Murtomäki, S., Trenkner, E., Wright, J.M., Saksela, O. and Liesi, P., Increased proteolytic activity of the granule neurons may contribute to neuronal death in the weaver mouse cerebellum, Dev. Biol., 168 (1995) 635-648.
28. Naudon, L., Leroux-Nicollet, I., Raisman-Vozari, R., Botton, D. and Constentin, J., Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex, Synapse, 21 (1995) 29-36.
29. Nierenberg, M.J., Vaughan, R.A., Uhl, G.R., Kuhar, M.J. and Pickel, V.M., The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons, J. Neurosci., 16 (1996) 436-447.
30. Patil, N., Cox, D.R., Bhat, D., Faham, M., Myers, R.M. and Peterson, A.S., A potasium channel mutation in weaver mice implicates membrane excitability in granule differentiation, Nature Genet., 11 (1995) 126-129.
31. Perrone-Capano, C., Tino, A. and di Porzio, U., Target cells modulate dopamine transporter gene expression during brain development, NeuroReport, 5 (1994) 1145-1148.
32. Rakik, P. and R.L., S., Organization of cerebellar cortex secondary to deficit of granule cell in weaver mutant mice, J. Comp. Neurol., 152 (1973) 133-162.
33. Rakik, R. and Sidman, R.L., Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice, J. Comp. Neurol., 152 (1973) 103-132.
34. Richter, J.A., Stotz, E.H., Ghetti, B. and Simon, J.R., Comparison of alterations in tyrosine hydroxylase, dopamine levels, and dopamine uptake in the striatum of the weaver mutant mouse, Neurochem. Res., 17 (1992) 437-441.
35. Roffler-Tarlov, S., The weaver mutation: a murin paradigm of Parkinson's disease. In F. Hefti and W.J. Weiner (Eds.), Progress in Parkinson's Disease Research, Vol. 2, Futura Publishing Co., Mount Kisco, NY, 1992, pp. 363-374.
36. Roffler-Tarlov, S. and Graybiel, A.M., Weaver mutant has differential effects on the dopamine-containing innervation of the limbic and non-limbic striatum, Nature, 307 (1984) 62-66.
37. Roffler-Tarlov, S., Martin, B., Graybiel, A.M. and Kauer, J.S., Cell death in the midbrain of the mutation weaver, J. Neurosci., 16 (1996) 1819-1826.
38. Roffler-Tarlov, S., Pugatch, D. and Graybiel, A.M., Patterns of cell and fiber vulnerability on the mesostriatal system of the mutant mouse weaver. II. High affinity uptakes sites for dopamine, J. Neurosci., 10 (1990) 734-740.
39. Schmidt, M.J., Sawyer, B.D., Perry, K.W., Foreman, M.M. and Ghetti, B., Dopamine deficiency in the weaver mutant mouse, J. Neurosci., 2 (1982) 376-380.
40. Shimada, S., Kitayama, S., Lin, C.-L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. and Uhl, G., Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA, Science, 254 (1991) 576-578.
41. Sidman, R.L., Angevine, J.B. and Taber Pierce, J.E., Atlas of the Mouse Brain and Spinal Cord, Harvard University Press, Cambridge, MA, 1971.
42. Sidman, R.L., Green, M.C. and Appel, S.H., Catalog of the Neurological Mutants of the Mouse, Harvard University Press, Cambridge, MA, 1965, pp. 66-67.
43. Simon, J.R. and Ghetti, B., Topographic distribution of dopamine uptake, choline uptake, choline acetyltransferase, and GABA uptake in the striata of weaver mutant mice, Neurochem. Res., 17 (1992) 431-436.
44. Simon, J.R. and Ghetti, B., The weaver mutant mouse as a model of nigrostial dysfunction, Mol. Neurobiol., 9 (1994) 183-189.
45. + channels, Neuron, 16 (1996) 321-331.
46. Sonsalla, P.K., Manzino, L. and Giovanni, A., Effect of long term MK-801 treatment on neurotoxicity of methamphetamine and MPTP in mice and rats, Soc. Neurosci. Abstr., 17 (1991) 702.
47. Stotz, E.H., Palacios, J.M., Landwehrmeyer, B., Norton, J., Ghetti, B., Simon, J.R. and Triarhou. L.C., Alterations in dopamine and serotine uptake systems in the striatum of weaver mutant house, J. Neural Transm. - Gen. Sect., 97 (1994) 51-64.
48. Triarhou. L.C., Weaver gene expression in central nervous system, Methods Neurosci., 9 (1992) 209-227.
49. Triarhou, L.C. and Ghetti, B., Monoaminergic nerve terminals in the cerebellar cortex of Purkinje cell degeneration mutant mice: Fine structural integrity and modification of cellular environs following loss of Purkinje and granule cells, Neuroscience, 18 (1986) 795-807.
50. Triarhou, L.C. and Ghetti, B., Neuroanatomical substrate of behavioural impairment in weaver mutant mice, Brain Res., 68 (1987) 434-435.
51. Triarhou, L.C. and Ghetti, B., The dendritic dopamine projection of the substantia nigra: phenotypic denominator of weaver gene action in hetero- and homozygosity, Brain Res., 501 (1989) 373-381.
52. Triarhou, L.C., Norton, J. and Ghetti, B., Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mice, Exp. Brain Res., 70 (1988) 256-265.
53. Triarhou, L.C., Norton, J. and Ghetti, B., Synaptic connectivity of tyrosine hydroxylase immunoreactive nerve terminals in the striatum of normal, heterozygous and homozygous weaver mutant mice, J. Neurocytol., 17 (1988) 221-232.
54. Uhl, G.R., Walther, D., Mash, D., Faucheux, B. and Javoy-Agid, F., Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons, Ann. Neurol., 35 (1994) 494-498.
55. Ungerstedt, U., 6-Hydroxydopamine induced degeneration of central monoamine neurons, Eur. J. Pharmacol., 5 (1968) 107-110.
56. Verney, C., Febret-Muzerelle, A. and Gaspar, P., Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant house, Dev. Brain Res., 89 (1995) 115-119.
57. Weiss-Wunder, T. and Chesselet, M.F., Subpopulation of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA, J. Comp. Neurol., 303 (1991) 478-488.
58. Zigmond, M.J. and Stricker, E.M., Animals models of parkinsonism using selective neurotoxins: clinical and basic implications, Int. Rev. Neurobiol., 31 (1989) 1-79.